Teva touches the lives and improves the health of people all over the globe every day. We are committed to changing the rules of the industry once again.
“We are creating breakthroughs in neurodegeneration. Teva’s National Network of Excellence will contribute to the quality of life of us all.”
“Copaxone and Azilect came from Israeli universities. Why wouldn’t we tap into this incredible expertise and innovation of Israeli Universities to find the next jewels.”
"Our single-minded focus, through the skills of our scientists, is to ensure that we bring essential generic medicines of high quality to the greatest number of in the fastest time possible."
“Today we can understand the processes resultingin disease and response to drugs in individual patients with greater precision than ever before.”
“Our NTE process reflects our expertise ingenerics and specialty drugs, and the synergiescreated when these capabilities are integrated.”
"Our collaboration with Teva will contribute greatly to the Korean pharmaceutical industry by supplying innovative medicines at affordable prices."
“In China there is an increasing demand forquality generic medication. We were very impressedby Teva's oncology, CNS and respiratory portfolio."
“Our DNA is the combination of P&G and Teva. Our mission is to understand what people wantand need, and then find innovative ways to deliver that.”
“We are excited to develop environmentally friendly technologies to create a healthier world for our customers worldwide.“
All News › Top News Jul 23, 2015 Teva Launches Educational Initiative to Arm Women with Facts about Emergency Contraception Learn More Share Top News Jul 23, 2015 Teva Issues Statement Learn More Share Top News Jul 21, 2015 Teva to Report Second Quarter 2015 Financial Results on July 30, 2015 Learn More Share Top News Jul 8, 2015 Teva First to Receive Approval and Launch Generic Axert® Tablets in the United States Learn More Share
Top News Jul 23, 2015 Teva Launches Educational Initiative to Arm Women with Facts about Emergency Contraception Learn More
Top News Jul 21, 2015 Teva to Report Second Quarter 2015 Financial Results on July 30, 2015 Learn More
Top News Jul 8, 2015 Teva First to Receive Approval and Launch Generic Axert® Tablets in the United States Learn More
Teva Recognized by Patients Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients. Making medicines accessible is key to patient groups Discover more
Fourth annual PatientView survey identifies Teva as a “Corporate Star” in the eyes of patients. Making medicines accessible is key to patient groups
Teva Helps Victims of Nepal Earthquake On April 25, a devastating earthquake hit Nepal and the surrounding areas. We are partnering with international non-profit organizations to respond to the most pressing needs on the ground with Teva products and medicines. Discover more
On April 25, a devastating earthquake hit Nepal and the surrounding areas. We are partnering with international non-profit organizations to respond to the most pressing needs on the ground with Teva products and medicines.
New R&D Center in Croatia The President of the Republic of Croatia, Dr. Ivo Josipović, officially opened Teva’s new R&D extension at PLIVA. Discover more
The President of the Republic of Croatia, Dr. Ivo Josipović, officially opened Teva’s new R&D extension at PLIVA.
How Our Uniqueness Creates Healthcare Confidence Around the world, people know that our ultimate goal is their health and well-being. Find out how we do it:
Around the world, people know that our ultimate goal is their health and well-being. Find out how we do it: